版本:
中国

BRIEF-Array Biopharma provides NEMO update

March 19 Array Biopharma Inc :

* Array Biopharma provides NEMO update

* Array Biopharma Inc - Has withdrawn from U.S. FDA division of oncology products 2 its new drug application (NDA) for binimetinib monotherapy

* Says ongoing clinical trials for binimetinib will continue

* Array Biopharma Inc - Withdrawl will not impact planned Phase 3 columbus trial NDA of binimetinib Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐